These constraints on the BTNX NTS are very appropriate, as we observed e.g. etodesnitazene to get an analogous in vitro potency and efficacy as fentanyl [7, 13] and as it could most likely give PWUD a false perception of basic safety. Also, the detectability of nitazene analogues in drug samples might be impacted by solubility troubles, as highligh